Browsing: DNA & Genetics

Atebimetinib, Immuneering’s lead deep cyclic inhibitor, in combination with chemotherapy shows durable tumor control and improved survival as a first-line…

Nearly 50 new cancer therapies are approved every year. While this positive trend is a huge benefit for patients, Altuna…

Helmholtz Munich and Parse Biosciences today announced a strategic partnership to generate the world’s broadest lung disease perturbation atlas, powered…

UC Davis researchers tracked the movement of fluorescent particles inside the cells of microscopic worms, providing novel insights into cellular…

Put on your thinking cap, and take on this fun challenge.

Inherently vulnerable to viral contamination, biologics rely on animal- or human-derived starting materials and complex manufacturing processes. Albeit rare, viral…

Image credit:Shelby BradfordFrom the moment she learned to write, Shelby Bradford was crafting stories. It began with reimagining story endings…

According to the latest study from BCC Research, the demand for “Global Market Opportunities and Competitive Landscape for CDMOs” was…

Alzheimer’s disease (AD) is the most common form of dementia affecting approximately 55 million people worldwide. In a new study…

Novo Nordisk (NASDAQ Copenhagen: NOVO-B) inflicted much pain—and much-needed pain—on the company when president and CEO Maziar (Mike) Doustdar announced…